Evaluation of Sleep Mode Within the Respironics SimplyGo Portable Oxygen Concentrator

Completed · Not applicable

Conditions studied: Lung Disease

In brief

The SimplyGo Study is a single site, cross-over study which aims to enroll a maximum of 30 participants (to allow for 20 completed data sets) with a prescription for nocturnal oxygen, and meeting all eligibility criteria.

Key facts

Study ID

NCT01679301

Run by

Philips Respironics

People needed

11

Starts

2012-09-01

Expected to finish

2014-07-01

Last updated by the study team

2018-11-16

Who can join

Age: 21 and older, up to 80. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Males and Females, ages 21-80
• Current prescription for supplemental oxygen at night; Can be pulsed dose or continuous
• Willing and able to provide informed consent

You may not qualify if…

• Medically unstable participants per discretion of the principal investigator
• Diagnosis of sleep apnea, per chart review, self report or rated high risk based on the Berlin Questionnaire
• Participants unable or unwilling to spend one night in a sleep lab
• Nocturnal oxygen requirements > 5 liters per minute
• Currently employed by a manufacturer of respiratory products or family member employed by a manufacturer of respiratory products
• Employee or family member that is affiliated with Philips

Where it is running

• Sukhdev Grover and Associates — Monroeville, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.